Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: More from the J3?

I have asked this question and will ask it again.

Why would Nec and Toshiba have requested the recently terminated 336 ex parte re-exam if there wasn't more to lose pursuant to the NDA and the settlement language?

I'm trying to understand what motivation they would have to pursue a re-exam when they had already settled in 2008. Unless, of course, the settlement included language that said "if the 336 prevails" you will pay more......much more.

One can only hope. Perhaps there is nothing more coming from the J3...meanwhile we are celebrating the positive turn of events today. Let's hope that it continues for all of us.

Laurie

Share
New Message
Please login to post a reply